{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:23:08Z","timestamp":1788877388528,"version":"build-2803163510"},"reference-count":53,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: Recent studies have shown that GABA reduces visceral hypersensitivity and improves intestinal permeability in a post-inflammatory irritable bowel syndrome (IBS) rat model. We aimed to assess the efficacy of a GABA-based supplement in IBS patients with diarrhea (IBS-D), focusing on symptoms relief, quality-of-life improvement, mucosal barrier function, systemic microinflammation and gut microbiota. Methods: In this double-blind, placebo-controlled, crossover study, 20 IBS-D patients were randomized to receive GABA or placebo for two four-week treatment periods separated by a two-week washout. Efficacy was assessed using IBS Symptom Severity Score (IBS-SSS) and Short-Form Health Survey-36 (SF-36). Circulating levels of lipopolysaccharide-binding protein (LBP), Tumor Necrosis Factor-\u03b1 (TNF-\u03b1) and interleukin (IL)-1\u03b2 were measured before and after each treatment. Results: Eighteen patients completed the study. A clinical response (\u226550-point reduction in IBS-SSS) was observed in 66.7% of patients during GABA treatment versus 33.3% with placebo. GABA produced a significant reduction in the IBS-SSS total score (p = 0.02) and in the bowel satisfaction item of the questionnaire (p = 0.02). Regarding quality of life, GABA significantly improved the \u201cEmotional limitation\u201d domain compared with placebo (p = 0.009). GABA treatment also led to a decrease in circulating LBP (p = 0.06) and IL-1\u03b2 (p = 0.02) levels compared to placebo, although only the reduction in IL-1\u03b2 reached statistical significance. In contrast, no substantial remodeling of the gut microbiota was observed. Conclusions: In this pilot study, GABA treatment led to a significant improvement in IBS-D symptoms compared with placebo and was also more effective in enhancing emotional wellbeing. GABA appeared to have a possible effect on intestinal permeability indirectly assessed through LBP, consistent with preclinical findings, and significantly reduced systemic inflammation. GABA may represent a promising therapeutic option for IBS, deserving further investigation in larger clinical trials.<\/jats:p>","DOI":"10.3390\/nu18101569","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:27:56Z","timestamp":1778776076000},"page":"1569","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of \u03b3-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Christian","family":"Lambiase","sequence":"first","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Cancelli","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Grosso","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3455-1794","authenticated-orcid":false,"given":"Francesco","family":"Rettura","sequence":"additional","affiliation":[{"name":"Gastroenterology Unit, Annunziata Hospital, Azienda Ospedaliera di Cosenza (AOCS), 87100 Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Salemmo","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5343-7271","authenticated-orcid":false,"given":"Andrea","family":"Bottari","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3309-763X","authenticated-orcid":false,"given":"Fabio","family":"Filippini","sequence":"additional","affiliation":[{"name":"Retrovirus Center, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1266-3931","authenticated-orcid":false,"given":"Stefano","family":"Salvadori","sequence":"additional","affiliation":[{"name":"Institute of Clinical Physiology, National Research Council, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Valdiserra","sequence":"additional","affiliation":[{"name":"Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9443-9919","authenticated-orcid":false,"given":"Letizia","family":"Campigli","sequence":"additional","affiliation":[{"name":"Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Antonioli","sequence":"additional","affiliation":[{"name":"Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-3959","authenticated-orcid":false,"given":"Matteo","family":"Fornai","sequence":"additional","affiliation":[{"name":"Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-1060","authenticated-orcid":false,"given":"Nicola","family":"de Bortoli","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6387-6443","authenticated-orcid":false,"given":"Massimo","family":"Bellini","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy"},{"name":"Regional Center for Functional and Motility Digestive Disorders, Azienda Ospedaliero-Universitaria Pisana, 56124 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel Disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_2","first-page":"8807","article-title":"Irritable Bowel Syndrome: A Disease Still Searching for Pathogenesis, Diagnosis and Therapy","volume":"20","author":"Bellini","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/00365520310004524","article-title":"Inflammatory Bowel Disease versus Irritable Bowel Syndrome: A Hospital-Based, Case-Control Study of Disease Impact on Quality of Life","volume":"38","author":"Pace","year":"2003","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/jgh.14375","article-title":"The Complex Interplay between Gastrointestinal and Psychiatric Symptoms in Irritable Bowel Syndrome: A Longitudinal Assessment","volume":"34","author":"Stasi","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bellini, M., Tosetti, C., Rettura, F., Morganti, R., Lambiase, C., Bassotti, G., Visaggi, P., Pancetti, A., Benedetto, E., and de Bortoli, N. (2022). Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133861"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"110566","DOI":"10.1016\/j.jpsychores.2021.110566","article-title":"Irritable Bowel Syndrome Prevalence and Work Ability in a Sample of Healthcare Workers Exposed to Occupational Stress","volume":"148","author":"Buselli","year":"2021","journal-title":"J. Psychosom. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.gastro.2019.10.036","article-title":"Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey","volume":"158","author":"Rangan","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ueg2.12259","article-title":"Functional Bowel Disorders with Diarrhoea: Clinical Guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility","volume":"10","author":"Savarino","year":"2022","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.dld.2022.11.015","article-title":"Italian Guidelines for the Management of Irritable Bowel Syndrome: Joint Consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), General Medicine (SIMG), Gastroenterology, Hepatology and Pediatric Nutrition (SIGENP) and Pediatrics (SIP)","volume":"55","author":"Barbara","year":"2023","journal-title":"Dig. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/gutjnl-2021-324598","article-title":"British Society of Gastroenterology Guidelines on the Management of Irritable Bowel Syndrome","volume":"70","author":"Vasant","year":"2021","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7869\/tg.2012.66","article-title":"Pro-Inflammatory and Anti-Inflammatory Cytokine Response in Diarrhoea-Predominant Irritable Bowel Syndrome Patients","volume":"33","author":"Rana","year":"2012","journal-title":"Trop. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrgastro.2016.141","article-title":"IBS and IBD\u2014Separate Entities or on a Spectrum?","volume":"13","author":"Spiller","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Gros, M., Gros, B., Mesonero, J.E., and Latorre, E. (2021). Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J. Clin. Med., 10.","DOI":"10.3390\/jcm10153429"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2014.12.001","article-title":"GABA and GABA Receptors in the Gastrointestinal Tract: From Motility to Inflammation","volume":"93","author":"Auteri","year":"2015","journal-title":"Pharmacol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hyland, N.P., and Cryan, J.F. (2010). A Gut Feeling about GABA: Focus on GABA(B) Receptors. Front. Pharmacol., 1.","DOI":"10.3389\/fphar.2010.00124"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2018.03.015","article-title":"Neurotransmitter Modulation by the Gut Microbiota","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lambiase, C., Rettura, F., Scium\u00e8, G.D., Tedeschi, R., Grosso, A., Cancelli, L., Bottari, A., Fornai, M., Antonioli, L., and de Bortoli, N. (2025). Targeting \u03b3-Aminobutyric Acid Pathways in Irritable Bowel Syndrome: Bridging Central Nervous System, Enteric Dysfunction, and the Microbiota-Gut-Brain Axis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1677037"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1113\/JP278025","article-title":"Peripheral GABA Receptors Regulate Colonic Afferent Excitability and Visceral Nociception","volume":"597","author":"McPherson","year":"2019","journal-title":"J. Physiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"121984","DOI":"10.1016\/j.lfs.2023.121984","article-title":"Activation of GABA Receptor Attenuates Intestinal Inflammation by Modulating Enteric Glial Cells Function through Inhibiting NF-\u03baB Pathway","volume":"329","author":"Deng","year":"2023","journal-title":"Life Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neuropharm.2008.09.006","article-title":"The GABA(B) Receptor Agonist, Baclofen, and the Positive Allosteric Modulator, CGP7930, Inhibit Visceral Pain-Related Responses to Colorectal Distension in Rats","volume":"56","author":"Brusberg","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5056\/jnm17100","article-title":"Dysregulation of GABAergic Signalling Contributes in the Pathogenesis of Diarrhea-Predominant Irritable Bowel Syndrome","volume":"24","author":"Aggarwal","year":"2018","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lucarini, E., Benvenuti, L., Di Salvo, C., D\u2019Antongiovanni, V., Pellegrini, C., Valdiserra, G., Ciampi, C., Antonioli, L., Lambiase, C., and Cancelli, L. (2024). Evaluation of the Beneficial Effects of a GABA-Based Product Containing Melissa officinalis on Post-Inflammatory Irritable Bowel Syndrome: A Preclinical Study. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1466824"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/gutjnl-2018-318160","article-title":"Efficacy of Pharmacological Therapies in Patients with IBS with Diarrhoea or Mixed Stool Pattern: Systematic Review and Network Meta-Analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/10715762.2019.1636045","article-title":"Contaminants: A Dark Side of Food Supplements?","volume":"53","author":"Costa","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"57810","DOI":"10.12775\/QS.2025.38.57810","article-title":"Contamination of Dietary Supplements: The Impact of the Undeclared Compounds on Health, Consequences of Daily Usage and Prevention Strategies","volume":"38","author":"Przygodzka","year":"2025","journal-title":"Qual. Sport"},{"key":"ref_27","unstructured":"(2021). Evaluation and Regulation of Food Supplements: European Perspective. Nutraceuticals, Academic Press."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0895-4356(98)00094-8","article-title":"The Italian SF-36 Health Survey: Translation, Validation and Norming","volume":"51","author":"Apolone","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The Irritable Bowel Severity Scoring System: A Simple Method of Monitoring Irritable Bowel Syndrome and Its Progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr. Scand."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/apt.13746","article-title":"Validity and Reliability of the Bristol Stool Form Scale in Healthy Adults and Patients with Diarrhoea-Predominant Irritable Bowel Syndrome","volume":"44","author":"Blake","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, Interactive, Scalable and Extensible Microbiome Data Science Using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-Resolution Sample Inference from Illumina Amplicon Data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA Ribosomal RNA Gene Database Project: Improved Data Processing and Web-Based Tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/s41592-025-02923-9","article-title":"MaAsLin 3: Refining and Extending Generalized Multivariable Linear Models for Meta-Omic Association Discovery","volume":"23","author":"Nickols","year":"2026","journal-title":"Nat. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2298\/JSC120712144J","article-title":"Validation of an HPLC Method for the Determination of Amino Acids in Feed","volume":"78","year":"2013","journal-title":"J. Serbian Chem. Soc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1564257","DOI":"10.1155\/2016\/1564257","article-title":"Rosmarinic Acid and Melissa officinalis Extracts Differently Affect Glioblastoma Cells","volume":"2016","author":"Ramanauskiene","year":"2016","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.phymed.2010.01.012","article-title":"Effects of Chronic Administration of Melissa officinalis L. Extract on Anxiety-like Reactivity and on Circadian and Exploratory Activities in Mice","volume":"17","author":"Ibarra","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Petkova, N.T., Zorovski, P., Ivanov, I., Dincheva, I., and Bileva, T. (2026). Bioactive Compounds and Antioxidant Activity in Lemon Balm (Melissa officinalis L.) Grown Under Different Growing Conditions. Sci, 8.","DOI":"10.3390\/sci8040077"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Petrisor, G., Motelica, L., Craciun, L.N., Oprea, O.C., Ficai, D., and Ficai, A. (2022). Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems\u2014A Review. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073591"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wang, C.-C., Hsieh, P.-W., Kuo, J.-R., and Wang, S.-J. (2021). Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABAA Receptor Activation. Biomolecules, 11.","DOI":"10.3390\/biom11071029"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/ptr.2712","article-title":"Bioassay-Guided Fractionation of Lemon Balm (Melissa officinalis L.) Using an In Vitro Measure of GABA Transaminase Activity","volume":"23","author":"Awad","year":"2009","journal-title":"Phytother. Res."},{"key":"ref_43","unstructured":"European Pharmacopoeia (Ph. Eur.) (2023). Melissa Leaf Dry Extract (Melissae Folium Extractum Siccum), Monograph No. 1844, Council of Europe. [11th ed.]."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","article-title":"The Impact of Irritable Bowel Syndrome on Health-Related Quality of Life","volume":"119","author":"Gralnek","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41538-025-00383-1","article-title":"Fructooligosaccharides and Aspergillus Enzymes Increase Brain GABA and Homocarnosine by Modulating Microbiota in Adolescent Mice","volume":"9","author":"Braga","year":"2025","journal-title":"npj Sci. Food"},{"key":"#cr-split#-ref_46.1","unstructured":"European Commission (2012). Guidance Document for Competent Authorities for the Control of Compliance with EU Legislation on Regulation"},{"key":"#cr-split#-ref_46.2","unstructured":"(EU) No 1169\/2011, Directive 90\/496\/EEC and Directive 2002\/46\/EC with Regard to the Setting of Tolerances for Nutrient Values Declared on a Label, European Commission. Available online: https:\/\/food.ec.europa.eu\/system\/files\/2016-10\/labelling_nutrition-vitamins_minerals-guidance_tolerances_1212_en.pdf."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2036.2005.02685.x","article-title":"Gabapentin Reduces Rectal Mechanosensitivity and Increases Rectal Compliance in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome","volume":"22","author":"Lee","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gut.2006.110858","article-title":"Effect of a Second-Generation A2\u03b4 Ligand (Pregabalin) on Visceral Sensation in Hypersensitive Patients with Irritable Bowel Syndrome","volume":"56","author":"Houghton","year":"2007","journal-title":"Gut"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41575-021-00423-7","article-title":"Enteric Glial Biology, Intercellular Signalling and Roles in Gastrointestinal Disease","volume":"18","author":"Seguella","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1007\/s00018-021-03881-z","article-title":"GABAergic Signaling by Cells of the Immune System: More the Rule than the Exception","volume":"78","author":"Bhandage","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1002\/jsfa.13634","article-title":"Regulation of Gut Microbiota and Serum Neurotransmitters in Mice by Streptococcus thermophilus GA8- and Lacticaseibacillus rhamnosus HAO9-Fermented Milk Containing High Levels of Gamma-Aminobutyric Acid","volume":"104","author":"Han","year":"2024","journal-title":"J. Sci. Food Agric."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/10\/1569\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:41:00Z","timestamp":1778776860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/10\/1569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":53,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["nu18101569"],"URL":"https:\/\/doi.org\/10.3390\/nu18101569","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}